Puerto Rico vs Sierra Leone: Prevalence rate of hypertension in women aged 30-79
Puerto Rico
43.2
in 2019
Sierra Leone
43.4
in 2019
Puerto Rico rank
34th
Sierra Leone rank
31st
Prevalence rate of hypertension in women aged 30-79 over time
- Puerto Rico
- Sierra Leone
How they compare
Sierra Leone currently reports 43.4 against 43.2 in Puerto Rico, a difference of 0.2.
Across all 30 years both countries report, Sierra Leone has been ahead every year.
Puerto Rico ranks 34th and Sierra Leone ranks 31st of 195 countries.
Sierra Leone has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Puerto Rico | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.57 | 40.54 | 2.97 | Sierra Leone |
| 2000s | 40.01 | 43.32 | 3.31 | Sierra Leone |
| 2010s | 42.6 | 43.93 | 1.33 | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Puerto Rico or Sierra Leone?
- Sierra Leone, at 43.4 against 43.2 in Puerto Rico as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Puerto Rico and Sierra Leone?
- 0.2, with Sierra Leone ahead.
- How many years of comparable data are there for Puerto Rico and Sierra Leone?
- 30 years are reported by both, from 1990 to 2019.
- How do Puerto Rico and Sierra Leone rank globally for prevalence rate of hypertension in women aged 30-79?
- Puerto Rico ranks 34th and Sierra Leone ranks 31st of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.